Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012
Crossref DOI link: https://doi.org/10.1007/s40121-017-0150-5
Published Online: 2017-03-11
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Keepers, Tiffany R.
Gomez, Marcela
Celeri, Chris
Krause, Kevin M.
Biek, Donald
Critchley, Ian
Funding for this research was provided by:
Cerexa, Inc. (Oakland, CA, USA), a subsidiary of Allergan plc